Stocks To Watch Today: IndusInd, Gensol, Tata Chemicals, SAIL, IRCTC
Infosys, Grasim Industries and DLF will be among the stocks that are likely to see action going into trade on Thursday.
IndusInd Bank Ltd., Gensol Engineering Ltd., Infosys Ltd., DLF Ltd. and Tata Chemicals Ltd., will be among the stocks that are likely to see action going into trade on Thursday.
IndusInd Bank: SEBI has barred former IndusInd Bank CEO Sumant Kathpalia and four others from dealing in the share market.
Gensol Engineering: The National Company Law Tribunal in Ahmedabad has ordered the freezing and attachment of all bank accounts and lockers belonging to Gensol Engineering and its associated entities.
Infosys: The company is in an agreement with E.ON to enable AI-powered digital workplace transformation.
Tata Chemicals: N Chandrasekaran resigned as director and chairperson, effective May 29, and appointed S Padmanabhan as director and chairperson, effective May 30.
DLF: The company's arm incorporated a wholly-owned subsidiary in GIFT City, Gujarat.
Grasim Industries: The board meeting will be held to consider the issue of Non-Convertible Debentures on a private placement basis, in one or more tranches, subject to regulatory and statutory approvals as may be required.
LTIMindtree: Aramco Digital and Co launched NextEra, which is a Next-Gen IT services company in Saudi Arabia.
Adani Energy Solutions: The board will meet on May 31 to consider a proposal for raising funds.
Aurobindo Pharma: The company incorporated a step-down arm, Curateq Biologics B.V., in Netherlands.
Schaeffler India: The company inaugurated a plant in Shoolagiri, Tamil Nadu.
FSN E-Commerce: NCLT approved the Scheme of Amalgamation of its arm Iluminar Media with Nykaa Fashion.
Earnings Reactions To Watch
Deepak Nitrite Q4 Highlights (Consolidated, YoY)
Revenue up 2.5% to Rs 2,179.69 crore versus Rs 2,126.21 crore.
Ebitda up 5% to Rs 316.51 crore versus Rs 301.12 crore.
Margin at 14.5% versus 14.2%.
Net Profit down 20% to Rs 202.41 crore versus Rs 253.86 crore.
Exceptional Gain of Rs 79.8 cr in Q4 FY24
Cummins India Q4 Highlights (Standalone, YoY)
Revenue up 6.1% to Rs 2,457 crore versus Rs 2,316 crore (Estimate: Rs 2,693 crore).
Ebitda down 4.4% to Rs 520 crore versus Rs 544 crore (Estimate: Rs 523 crore).
Ebitda margin at 21.2% versus 23.5% (Estimate: 19.4%).
Net profit down 7% to Rs 521 crore versus Rs 561 crore (Estimate: Rs 476 crore).
Domestic sales were higher by 1% compared to the same quarter last year and lower by 25% compared to the previous quarter.
Exports sales are higher by 39% compared to the same quarter last year and higher by 3% compared to the previous quarter.
Insecticides (India) Q4 Highlights (Consolidated, YoY)
Revenue up 31.7% to Rs 359 crore versus Rs 272.5 crore.
Ebitda to Rs 28.5 crore versus Rs 8.7 crore.
Margin at 7.9% versus 3.2%.
Net Profit up 84.7% to Rs 13.9 crore versus Rs 7.5 crore.
Deferred Tax Credit of 4 crore in Q4 FY24
Revenue Growth of 32% is registered in Q4 vs Q4FY24 with significant improvement in profit margins across segments
Premiumization led Profit Growth
A robust performance was noted in Shinwa, Izuki, Mission SC, Mycoraja and new launches.
Nuvama Wealth Management Q4 Highlights (Consolidated, QoQ)
Revenue up 8.3% to Rs 1,120 crore versus Rs 1,034 crore.
Ebitda down 1.2% to Rs 575 crore versus Rs 582 crore.
Margin at 51.3% versus 56.2%.
Net Profit up 1.3% to Rs 255 crore versus Rs 252 crore.
Ebitda Down due to an increase in other expenses by 40% and employee expenses by 22%.
Wealth Management Business Grew by 15%.
Capital Market Business grew by 25%
Bata India Q4 Highlights (Consolidated, YoY)
Revenue down 1.2% to Rs 788 crore versus Rs 798 crore.
Ebitda down 2% to Rs 178 crore versus Rs 182 crore.
Margin at 22.6% versus 22.8%.
Net Profit down 27.9% to Rs 45.9 crore versus Rs 63.6 crore.
Birlasoft Q4 (Consolidated, YoY)
Revenue down 3.31% at Rs 1317 crore versus Rs 1362 crore.
EBIT up 7.47% at Rs 152.5 crore versus Rs 141.9 crore.
EBIT margin up 116 bps at 11.57% versus 10.41%.
Net profit up 4.27% at Rs 122 crore versus Rs 117 crore.
Welspun Corp Q4 Highlights (Cons, YoY)
Revenue down 12% at Rs 3,925 crore versus Rs 4,461 crore
EBITDA up 39.4% at Rs 460 crore versus Rs 330 crore
Margin At 11.7% Vs 7.4%
Net Profit at Rs 698 crore versus Rs 269 crore.
Exceptional Gain of Rs 476 crore.
SAIL Q4 Highlights (Consolidated, QoQ)
Revenue up 19.7% to Rs 29,316.14 crore versus Rs 24,489.91 crore.
Ebitda up 72% to Rs 3,483.86 crore versus Rs 2,029.87 crore.
Margin at 11.9% versus 8.3%.
Net Profit up 393% to Rs 1,251.00 crore versus Rs 253.86 crore.
Exceptional Loss of Rs 29 crore vs 28 crore Exceptional Gain.
Other Income increases by 27%, from 297 cr vs 233 cr.
Total Expenses at 28,029 cr vs 24,560 cr.
Avanti Feeds Q4 Highlights (Consolidated, YoY)
Revenue up 7.9% to Rs 1,385 crore versus Rs 1,284 crore.
Ebitda up 36.5% to Rs 177 crore versus Rs 130 crore.
Margin at 12.8% versus 10.1%.
Net Profit up 45.8% to Rs 152 crore versus Rs 104 crore.
Other Income increased by 36% from 49.88 cr vs 36.45 cr.
IRCTC Q4 Highlights (Consolidated, YoY)
Revenue up 10.1% to Rs 1,268.52 crore versus Rs 1,151.71 crore.
Ebitda up 6% to Rs 385.48 crore versus Rs 362.43 crore.
Margin at 30.4% versus 31.5%.
Net Profit up 26% to Rs 358.22 crore versus Rs 284.18 crore.
Exceptional gain of Rs 45.68 crore in the fourth quarter.
FDC Q4 Highlights (Consolidated, YoY)
Revenue up 6.5% to Rs 492 crore versus Rs 462 crore.
Ebitda down 4.2% to Rs 54 crore versus Rs 56.3 crore.
Margin at 11% versus 12.2%.
Net Profit down 16.4% to Rs 38.7 crore versus Rs 46.3 crore.
Cohance Lifesciences Q4 Highlights (Consolidated, YoY)
Revenue up 30.5% to Rs 330 crore versus Rs 253 crore.
Ebitda down 8.4% to Rs 67.2 crore versus Rs 73.3 crore.
Margin at 20.3% versus 29%.
Net Profit down 16.7% to Rs 44.3 crore versus Rs 53.2 crore.
Heidelbergcement India Q4 Highlights (YoY)
Revenue up 2.7% to Rs 612 crore versus Rs 597 crore.
Ebitda up 2% to Rs 90.6 crore versus Rs 89 crore.
Margin at 14.8% versus 14.9%.
Net Profit up 4.8% to Rs 50.5 crore versus Rs 48 crore.
Jindal Worldwide Q4 Highlights (Consolidated, YoY)
Revenue up 5.5% to Rs 606 crore versus Rs 574 crore.
Ebitda down 11.8% to Rs 49 crore versus Rs 55.5 crore.
Margin at 8% versus 9.7%.
Net Profit down 21.8% to Rs 22 crore versus Rs 28.2 crore.
Natco Pharma Q4 Highlights (Consolidated, YoY)
Revenue up 14.3% to Rs 1,221 crore versus Rs 1,068 crore.
Ebitda up 10.2% to Rs 548 crore versus Rs 497 crore.
Margin at 44.9% versus 46.6%.
Net Profit up 5.3% to Rs 407 crore versus Rs 386 crore.
Earnings In Focus
Alkem Laboratories, Amara Raja Energy & Mobility, Bajaj Auto, Mrs. Bectors Food Specialities, Campus Activewear, Century Plyboards (India), Concord Biotech, Confidence Petroleum India, Engineers India, Gujarat Pipavav Port, ICRA, IPCA Laboratories, ISGEC Heavy Engineering, JNK India, KNR Constructions, Landmark Cars, Lemon Tree Hotels, Lumax Auto Technologies, Mazagon Dock Shipbuilders, Samvardhana Motherson International, NBCC (India), Ola Electric Mobility, Procter & Gamble Health, Prestige Estates Projects, Samhi Hotels, Shivalik Bimetal Controls, Senco Gold, Shalby, SJVN, Sobha, Suzlon Energy, Tarc, Technocraft Industries (India), Varroc Engineering, Welspun Living, Wockhardt Yatra Online.
